Agalsidase beta 5mg powder for solution for infusion vials
previously Agalsidase beta 5mg powder for solution for injection vials
- SNOMED code
41758111000001109
previously413468006- Code valid from
- Named
- Active compound
- Agalsidase beta
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Agalsidase beta
— 5 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi)
in short Fabrazyme 5mg pdr for concentrate for inf vials
previously Fabrazyme 5mg powder for solution for infusion vials
Fabrazyme 5mg powder for concentrate for solution for infusion vials
- SNOMED code
9524311000001108- Named
- Supplier
- Sanofi
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi) 1 vial9524411000001101 ref. pack | 💯 Available Legal category: POM | 5030045000166 | NHS Indicative Price £315.8 previously: £325.50 | • Personally Administered |
| — |
Reference packs
Agalsidase beta 5mg powder for solution for infusion vials 1 vial
- SNOMED code
9524211000001100- Quantity and unit
- 1 vial
- Packs